Memphasys Limited Contact Details E [email protected] Level 1, 34-36 Richmond Road P +612 8415 7300 W memphasys.com Homebush West, NSW 2140 ABN 33 120 047 556 ASX Release 21 August...
Memphasys: Results of General Meeting
Filed with ASX ·
6ix hasn’t read this filing yet.
Earlier from Memphasys
- Felix Registration Achieved in Vietnam and Cartridge Order
- Pivotal Felix Study Receives First Scientific Presentation
- European Commercial Roll-out continues with Poland Agreement
- Exclusive Thailand Commercialisation Agreement Secured
- UK Market Entry & Acceleration of Commercial Expansion
Later from Memphasys
- Felix Early Thai FDA Approval, Commercial Launch Accelerates
- Appendix 4E and 2026 Annual Report
- Appendix 4G and Corporate Governance Statement
- EUR526,500 Nordic Agreement Expands Felix European Footprint
- Notification of cessation of securities - MEM
Follow Memphasys into a list and get an email when it puts out news.
Follow Memphasys